Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MD Mednax Inc
- Stocks
- Healthcare
- NYSE: MD
Price (delayed)
$13.22
Market cap
$1.14B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.99
Enterprise value
$1.69B
Mednax, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of Mednax are reshaping the delivery of
Highlights
The quick ratio has grown by 21% since the previous quarter and by 6% year-on-year
The debt has decreased by 16% YoY
The company's EPS rose by 17% QoQ but it fell by 15% YoY
The net income rose by 17% since the previous quarter but it has declined by 17% year-on-year
Key stats
What are the main financial stats of MD
Market
Valuations
Earnings
Shares outstanding
85.91M
Market cap
$1.14B
Enterprise value
$1.69B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.44
Price to sales (P/S)
0.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.86
Revenue
$1.98B
Gross profit
$462.11M
Operating income
-$42.81M
Net income
-$82.37M
EBIT
-$41.78M
EBITDA
-$14.53M
Free cash flow
$194.33M
Per share
Balance sheet
Liquidity
EPS
-$0.99
EPS diluted
-$1
Free cash flow per share
$2.3
Book value per share
$9.19
Revenue per share
$23.4
TBVPS
$8.77
Total assets
$1.99B
Total liabilities
$1.2B
Debt
$655.32M
Equity
$789.19M
Working capital
$220.62M
Debt to equity
0.83
Current ratio
1.81
Quick ratio
1.7
Net debt/EBITDA
-38.3
Margins
Efficiency
Dividend
EBITDA margin
-0.7%
Gross margin
23.4%
Net margin
-4.2%
Operating margin
-2.2%
Return on assets
-4%
Return on equity
-11%
Return on invested capital
-4.1%
Return on capital employed
-2.4%
Return on sales
-2.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MD stock price
How has the Mednax stock price performed over time
Intraday
-0.97%
1 week
-5.57%
1 month
-12.8%
1 year
71.47%
YTD
0.76%
QTD
-8.76%
Financial performance
How have Mednax's revenue and profit performed over time
Revenue
$1.98B
Gross profit
$462.11M
Operating income
-$42.81M
Net income
-$82.37M
Gross margin
23.4%
Net margin
-4.2%
MD's operating income is up by 27% since the previous quarter
The operating margin has increased by 24% since the previous quarter
The net margin has decreased by 20% YoY but it has increased by 14% from the previous quarter
The net income rose by 17% since the previous quarter but it has declined by 17% year-on-year
Price vs fundamentals
How does MD's price correlate with its fundamentals
Growth
What is Mednax's growth rate over time
Valuation
What is Mednax stock price valuation
P/E
N/A
P/B
1.44
P/S
0.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.86
The company's EPS rose by 17% QoQ but it fell by 15% YoY
The P/B is 20% below the 5-year quarterly average of 1.8 but 11% above the last 4 quarters average of 1.3
The equity is down by 8% YoY but it is up by 3.2% QoQ
The stock's price to sales (P/S) is 30% less than its 5-year quarterly average of 0.8 but 12% more than its last 4 quarters average of 0.5
Efficiency
How efficient is Mednax business performance
The ROIC has plunged by 156% YoY but it is up by 27% from the previous quarter
The company's return on sales has shrunk by 133% YoY but it rose by 30% QoQ
MD's return on equity is down by 41% year-on-year but it is up by 15% since the previous quarter
The ROA has contracted by 29% YoY but it has grown by 15% from the previous quarter
Dividends
What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MD.
Financial health
How did Mednax financials performed over time
The total assets is 66% greater than the total liabilities
The company's current ratio rose by 23% QoQ and by 5% YoY
The quick ratio has grown by 21% since the previous quarter and by 6% year-on-year
The debt is 17% less than the equity
The debt has decreased by 16% YoY
MD's debt to equity is down by 9% year-on-year and by 4.6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.